C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. Net Income 2021–2025
C4 Therapeutics Inc. annual/quarterly net income history and growth rate from 2021 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- C4 Therapeutics Inc. net income for the quarter ending March 31, 2026 was -25.1 M, a 4.53% decrease year-over-year.
- C4 Therapeutics Inc. net income for the twelve months ending March 31, 2026 was -109.6 M, a 12.13% increase year-over-year.
- C4 Therapeutics Inc. annual net income for 2025 was -105.0 M, a 0.31% decrease from 2024.
- C4 Therapeutics Inc. annual net income for 2024 was -105.3 M, a 20.51% decrease from 2023.
- C4 Therapeutics Inc. annual net income for 2023 was -132.5 M, a 3.37% increase from 2022.
- C4 Therapeutics Inc. annual net income for 2022 was -128.2 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
C4 Therapeutics Inc. Net Income — FAQ
C4 Therapeutics Inc. (CCCC) net income over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
What is C4 Therapeutics Inc.'s net income?
C4 Therapeutics Inc. (CCCC) reported net income of -$105M for fiscal 2025.
Where can I see CCCC's net income history?
The chart and table above show C4 Therapeutics Inc.'s net income by year and by quarter, including the growth rate.